Last €9.40 EUR
Change Today -0.093 / -0.98%
Volume 0.0
MXE On Other Exchanges
As of 2:53 AM 12/23/14 All times are local (Market data is delayed by at least 15 minutes).

mimedx group inc (MXE) Snapshot

Previous Close
Day High
Day Low
52 Week High
12/22/14 - €9.87
52 Week Low
05/8/14 - €3.59
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for MIMEDX GROUP INC (MXE)

Related News

No related news articles were found.

mimedx group inc (MXE) Related Businessweek News

No Related Businessweek News Found

mimedx group inc (MXE) Details

MiMedx Group, Inc., together with its subsidiaries, designs, manufactures, and markets products and tissue processing services in the United States. The company’s products include patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane. Its biomaterial platform technologies comprise AmnioFix and EpiFix, which are tissue technologies processed from human amniotic membrane that is derived from donated placentas. Through the company’s donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. It processes the human amniotic membrane utilizing its proprietary PURION process to produce a safe and effective implant. The company also provides CollaFix, a medical device technology platform. It supplies amniotic tissue on OEM basis for application in the wound care, surgical, sports medicine, ophthalmic, and dental sectors of healthcare through direct sales force, independent sales representatives, and distributors, as well as through private label or OEM relationships. The company is headquartered in Marietta, Georgia.

222 Employees
Last Reported Date: 03/4/14

mimedx group inc (MXE) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $465.2K
President, Chief Operating Officer and Direct...
Total Annual Compensation: $385.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $268.3K
Vice President, General Counsel and Consultan...
Total Annual Compensation: $240.0K
Compensation as of Fiscal Year 2013.

mimedx group inc (MXE) Key Developments

MiMedx Group, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 11:30 AM

MiMedx Group, Inc. Presents at Oppenheimer 25th Annual Healthcare Conference, Dec-10-2014 11:30 AM. Venue: The Crowne Plaza Hotel, New York, New York, United States. Speakers: Parker H. Petit, Chairman and Chief Executive Officer.

MiMedx Group, Inc. Presents at Brean Capital Life Sciences Summit, Nov-24-2014

MiMedx Group, Inc. Presents at Brean Capital Life Sciences Summit, Nov-24-2014 . Venue: Convene (Formerly Sentry Centers), 730 3rd Avenue, New York, New York, United States.

MiMedx Group, Inc. Appoints Christopher M. Cashman as Executive Vice President & Chief Commercialization Officer

MiMedx Group, Inc. announced that Christopher M. Cashman has joined MiMedx as the company's Executive Vice President & Chief Commercialization Officer. In his new role, Mr. Cashman will contribute his expertise to the company's sales & marketing functions, strategic planning and all related revenue growth initiatives. Most recently, Mr. Cashman was President and Chief Executive Officer of SANUWAVE Health. Before joining SANUWAVE, he served as President of Therapeutic Surfaces for Kinetic Concepts, Inc.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MXE:GR €9.40 EUR -0.093

MXE Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Shire PLC 4,470 GBp -63.00
View Industry Companies

Industry Analysis


Industry Average

Valuation MXE Industry Range
Price/Earnings 100.0x
Price/Sales 12.8x
Price/Book 15.4x
Price/Cash Flow 653.3x
TEV/Sales 12.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MIMEDX GROUP INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at